Effectiveness, Adverse Effects and Drug Compliance of Long-Acting Injectable Risperidone in Children and Adolescents.

Creative Commons License

Ceylan M. F., Erdogan B., Hesapcioglu S., Cop E.

Clinical drug investigation, vol.37, no.10, pp.947-956, 2017 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 10
  • Publication Date: 2017
  • Doi Number: 10.1007/s40261-017-0555-7
  • Journal Name: Clinical drug investigation
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.947-956
  • Ankara Yıldırım Beyazıt University Affiliated: Yes


Background and Objectives Although the use of oral risperidone in children and adolescents has been well studied, there is little information on the intramuscular use of long-acting injectable risperidone (LAIR). The aims of this study were to investigate the effectiveness and adverse effects of LAIR in children and adolescents with conduct disorder, bipolar disorder, and schizophrenia.